Skip to content
Subscribe

New Cannabis Initiative Offers Solutions for Drug Testing, DUIs

Published:

A new marijuana legalization initiative, pending review by California’s Attorney General, is seeking access to the 2014 ballot. The California Cannabis Hemp Initiative of 2014 hopes to be the green light marijuana activists have been searching for in the Golden State.

The CCHI aims to legalize all forms of cannabis hemp products, specifically stating those that are categorized as industrial, medicinal, nutritional, and euphoric products. Industrially, this can include fuel, paper, clothing, and plastics.

Medicinally, it can be used for treatments corresponding to serious medical conditions, including Alzheimer’s disease, cancer, glaucoma, and multiple sclerosis. The euphoric portion of legalization addresses the legality of use for recreational purposes by people over 21 years of age.

Voters and proponents, however, may be skeptical since past cannabis initiatives have been rejected in California.

The 2012 election saw five cannabis initiatives all fighting for a spot on the ballot and, consequently, none made it. The array of initiatives caused fragmentation within the legalization movement that made it difficult to acquire funding.

“We’re all chasing the same dollars," said Steve Collett of the Regulate Marijuana Like Wine initiative .If similarly competing initiatives arise, the California Cannabis Hemp Initiative of 2014 could meet the same fate as the California Cannabis Hemp

Initiative of 2012. The 2012 initiative was submitted by the same sponsors -- Michael Jolson, and Berton Duzy. It did not receive the signatures needed to appear on the ballot.

Proposition 19 -- the Regulate, Control and Tax Cannabis Act of 2010 -- did make the ballot, but failed with 53.5 percent of the vote opposing it. The major concern cited by the California Police Chief’s Association was that Prop. 19 did not include a definition of driving under the influence. The proposition could have created situations where a person can drive, “even if a blood test shows they have marijuana in their system”.

The California Chamber of Commerce worried about the restrictions for employer's current drug testing abilities. Their complaints stated that they would not possess the power to take action until after an accident had occurred.

The CCHI’s language on the issues of the drug testing covers what Prop. 19 did not:

"No person shall be required to submit to testing for inactive and/or inert residual cannabis metabolites as a condition of any right or privilege including employment or insurance, nor may the presence of such metabolites be considered in determining employment, other impairment, or intoxication. Testing for active (not metabolized) cannabis may be used and considered in determining employment, impairment, or intoxication."

As drug testing currently stands, a citizen can be denied from a job, or considered worthy of a DUI, for testing positive for marijuana metabolites. Marijuana advocates cite the problem with this being that marijuana metabolites can last up to 6 weeks, even though the effects of the drug only last for a few hours.

In response to police concerns about driving impaired, the CCHI calls for lawmakers to treat marijuana similar to alcohol:

“Determine an acceptable and uniform standard of impairment based on scientifically acceptable performance testing to restrict persons impaired by cannabis hemp euphoric products from operating a motor vehicle or heavy machinery, or otherwise engaging in conduct that may affect public safety.”

These stipulations may not stifle opposition, but they do provide more specific aims that should address oppositional concerns without sacrificing their goal to improve legal treatment of marijuana users.

The California Cannabis Hemp Initiative of 2014 has a long road just to get on the ballot, but it provides drug testing details that failed attempts missed. Marijuana legalization now has public opinion, medical opinion, and legal precedent on its side, something previous California marijuana initiatives did not.

Adhere to the IVN etiquette

By posting a comment, you agree to adhere to our etiquette rules: No partisan attacks, no personal attacks, substantiate your sources, no self-promotion.

Contact IVN

Questions about this article or our coverage? Send us a message. A free IVN member account is required.

Message sent

Thanks, we’ll review it and get back to you if needed.

Message not sent

Sorry, something went wrong. Please try again.

Sign in to send a message

Messages are tied to your IVN member account. Signing in is free and takes a few seconds.

Contact IVN

Questions about this article or our coverage? Send us a message. A free IVN member account is required.

Message sent

Thanks, we’ll review it and get back to you if needed.

Message not sent

Sorry, something went wrong. Please try again.

Sign in to send a message

Messages are tied to your IVN member account. Signing in is free and takes a few seconds.

Republish this article

Republishing guidelines

Republish IVN articles for free. Independent Voter News articles may be republished online or in print under a Creative Commons BY-NC-ND 4.0 license, on these terms:

  1. Credit the author and IVN. Keep the byline ("By Author Name, Independent Voter News") and the attribution note at the end, which links to the original.
  2. Keep the meaning. You may update time and place references and apply your house style. You may trim for length, as long as the cuts don't change the meaning or misrepresent the author. Keep the headline. Mark any additions as your own (for example "Additional reporting by ...").
  3. Translations are welcome. Translate faithfully, add "Translated from English by [your outlet]", and tell us at editor@ivn.us.
  4. Keep the links, including the link to the original article.
  5. Keep the tracking image. The HTML includes a 1-pixel image that counts readers on your page. It collects no personal information.
  6. Photos and illustrations. Images credited to IVN may be used with this article only. Images credited to others (AP, Getty, Unsplash, Wikimedia and so on) stay under their owners' terms. Secure the rights or switch "Include images" off.
  7. Don't sell it. You can't sell our articles or sell ads specifically against them. Your normal site advertising is fine.
  8. No implied endorsement. Don't suggest that IVN or the author endorses you, your candidates or your causes, or that donations to you support IVN.
  9. Keep labels. Opinion or analysis pieces keep that label.
  10. Point search engines to the original. Where your CMS allows, set the canonical URL to the original IVN article.
  11. No bulk or automated republishing, and don't submit our articles to aggregators (Apple News, Google News, MSN) as your own.
  12. Corrections and removals. Update your copy when we correct it, and remove it promptly if we ask. We'll contact you at the email you give us.
  13. Questions or print republication: editor@ivn.us.

IVN staff: fill in who you're inviting above, then create the invite.

Preparing the article

New Cannabis Initiative Offers Solutions for Drug Testing, DUIs

Choose a format
  • HTML
  • Email HTML
  • Markdown
  • Formatted (.docx)
  • Plain text
  • WordPress blocks
  • PDF
Choose a platform

Photos credited to others need their owners' permission.

To for

Republishing somewhere else? Questions? editor@ivn.us